Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques-Eric Gottenberg

Showing results (41-50 of 311) with videos related to

Pageof 32
Sort By:
Annals of the Rheumatic Diseases|October 17, 2006
Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF productionFrédéric Lavie, Corinne Miceli-Richard, Marc Ittah, et al.
European Journal of Immunology|April 2, 2009
B-cell-activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA-activated protein kinase activationMarc Ittah, Corinne Miceli-Richard, Jacques-Eric Gottenberg, et al.
The Journal of Rheumatology|May 18, 2010
Tumor necrosis factor-alpha blockers in SAPHO syndromeKaouther Ben Abdelghani, Delphine Gerard Dran, Jacques-Eric Gottenberg, et al.
Joint Bone Spine|September 24, 2018
Identification of cartilage oligomeric matrix protein as biomarker predicting abatacept response in rheumatoid arthritis patients with insufficient response to a first anti-TNFα treatmentMinh Vu Chuong Nguyen, Annie Adrait, Athan Baillet, et al.
Expert Review of Clinical Immunology|March 21, 2014
Classification criteria and treatment modalities in primary Sjögren's syndromeAlia Fazaa, Tristan Bourcier, Emmanuel Chatelus, et al.
Arthritis Research & Therapy|December 3, 2013
B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosisAntoine François, Emmanuel Chatelus, Dominique Wachsmann, et al.
Arthritis and Rheumatism|October 2, 2007
BAFF synthesis by rheumatoid synoviocytes is positively controlled by alpha5beta1 integrin stimulation and is negatively regulated by tumor necrosis factor alpha and Toll-like receptor ligandsGhada Alsaleh, Laurent Messer, Noha Semaan, et al.
Autoimmunity Reviews|June 10, 2018
The 2018 pipeline of targeted therapies under clinical development for Systemic Lupus Erythematosus: a systematic review of trialsRenaud Felten, Elida Dervovic, François Chasset, et al.
Arthritis Research & Therapy|July 10, 2010
Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritisGhada Alsaleh, Laetitia Sparsa, Emmanuel Chatelus, et al.
Rheumatology (Oxford, England)|August 1, 2006
Sjogren's syndrome is associated with and not secondary to systemic sclerosisCarine Salliot, Luc Mouthon, Marc Ardizzone, et al.
Pageof 32

Showing results (41-50 of 311) with videos related to

Sort By:
Pageof 32
Annals of the Rheumatic Diseases|October 17, 2006
Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF productionFrédéric Lavie, Corinne Miceli-Richard, Marc Ittah, et al.
European Journal of Immunology|April 2, 2009
B-cell-activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA-activated protein kinase activationMarc Ittah, Corinne Miceli-Richard, Jacques-Eric Gottenberg, et al.
The Journal of Rheumatology|May 18, 2010
Tumor necrosis factor-alpha blockers in SAPHO syndromeKaouther Ben Abdelghani, Delphine Gerard Dran, Jacques-Eric Gottenberg, et al.
Joint Bone Spine|September 24, 2018
Identification of cartilage oligomeric matrix protein as biomarker predicting abatacept response in rheumatoid arthritis patients with insufficient response to a first anti-TNFα treatmentMinh Vu Chuong Nguyen, Annie Adrait, Athan Baillet, et al.
Expert Review of Clinical Immunology|March 21, 2014
Classification criteria and treatment modalities in primary Sjögren's syndromeAlia Fazaa, Tristan Bourcier, Emmanuel Chatelus, et al.
Arthritis Research & Therapy|December 3, 2013
B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosisAntoine François, Emmanuel Chatelus, Dominique Wachsmann, et al.
Arthritis and Rheumatism|October 2, 2007
BAFF synthesis by rheumatoid synoviocytes is positively controlled by alpha5beta1 integrin stimulation and is negatively regulated by tumor necrosis factor alpha and Toll-like receptor ligandsGhada Alsaleh, Laurent Messer, Noha Semaan, et al.
Autoimmunity Reviews|June 10, 2018
The 2018 pipeline of targeted therapies under clinical development for Systemic Lupus Erythematosus: a systematic review of trialsRenaud Felten, Elida Dervovic, François Chasset, et al.
Arthritis Research & Therapy|July 10, 2010
Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritisGhada Alsaleh, Laetitia Sparsa, Emmanuel Chatelus, et al.
Rheumatology (Oxford, England)|August 1, 2006
Sjogren's syndrome is associated with and not secondary to systemic sclerosisCarine Salliot, Luc Mouthon, Marc Ardizzone, et al.
Pageof 32